09/24/2017
https://www.fda.gov/Drugs/DrugSafety/ucm500143.htm
[05-12-2016] The U.S. Food and Drug Administration is advising that the serious side effects associated with fluoroquinolone antibacterial drugs generally outweigh the benefits for patients with sinusitis, bronchitis, and uncomplicated urinary tract infections.